FDA Adverse Event Malfunction Summary report: N

BD PROTECTOR P50

MDR report key: 9586988 · Received January 14, 2020

Report

Report Number
3003152976-2020-00004
Event Type
Malfunction
Date Received
January 14, 2020
Date of Event
November 22, 2019
Report Date
March 23, 2020
Manufacturer
BECTON DICKINSON, S.A.
Product Code
ONB
UDI-DI
30382905151058
PMA / PMN Number
K123213
Adverse Event
Yes
Product Problem
Yes
Report Source
Manufacturer report
Reporter Location
TU
Reporter Occupation
OTHER HEALTH CARE PROFESSIONAL

Narratives

Additional Manufacturer Narrative · 0

H.6. INVESTIGATION SUMMARY ONE PHOTO SAMPLE AND ONE UNUSED PROTECTOR SAMPLE WAS PROVIDED TO OUR QUALITY TEAM FOR INVESTIGATION. UPON VISUALLY INSPECTING THE PHOTO, A GREY PARTICLE INSIDE THE VIAL CAN BE OBSERVED. WITHOUT THE ACTUAL SAMPLE TO EVALUATE, WE CANNOT VERIFY THE ORIGIN OF THE PARTICLE. THE UNUSED SAMPLE WAS EVALUATED, NO ISSUES WERE IDENTIFIED AND NO PARTICLES WERE OBSERVED AFTER FUNCTIONAL TESTING. A DEVICE HISTORY REVIEW WAS PERFORMED FOR LOT 1905122, NO DEVIATIONS OR NON-CONFORMANCES WERE IDENTIFIED DURING THE MANUFACTURING PROCESS THAT COULD HAVE CONTRIBUTED TO THESE ISSUES. FRAGMENTATION TESTING IS PERFORMED DURING MANUFACTURING TO EVALUATE ANY PARTICULATES GENERATED AFTER TEN ACTIVATIONS. TESTING RESULTS WERE REVIEWED FOR THE REPORTED LOT AND RESULTS WERE FOUND TO BE ACCEPTABLE. FOUR RETAINED SAMPLES OF LOT 1905122 WERE USED FOR ADDITIONAL EVALUATION. FUNCTIONAL TESTING WAS ALSO PERFORMED, PENETRATING THE PROTECTOR WITH A SAMPLE INJECTOR TEN TIMES. IN ALL CASES THE PRODUCT FUNCTIONED AS INTENDED AND NO CORING WAS IDENTIFIED. WHILE PHASEAL NEEDLES ARE DESIGNED TO REDUCE CORING, THERE ARE SEVERAL FACTORS THAT MAY IMPACT CORING TENDENCY. CORING FROM THE MEMBRANE MAY OCCUR DUE TO FRAGMENTATION CAUSED BY MULTIPLE INJECTIONS OR EXCESSIVE WELDING OF THE MEMBRANE. CORING OF THE RUBBER STOPPER MAY RESULT DEPENDING ON THE STOPPER QUALITY, THE DESIGN AND DIMENSIONS OF THE NEEDLES USED, OR IF A POOR CONNECTION OF THE PROTECTOR OCCURS. BASED ON THE QUALITY TEAM'S INVESTIGATION, WE ARE NOT ABLE TO IDENTIFY A DEFINITIVE ROOT CAUSE RELATED TO OUR MANUFACTURING PROCESS AT THIS TIME. COMPLAINTS RECEIVED FOR THIS DEVICE AND DEFECT WILL CONTINUE TO BE MONITORED BY OUR QUALITY TEAM.

Description of Event or Problem · 0

IT HAS BEEN REPORTED THAT THE BD¿ PROTECTOR P50 HAS BEEN FOUND CONTAINING FOREIGN MATTER DURING USE. THE FOLLOWING HAS BEEN PROVIDED BY THE INITIAL REPORTER: A PIECE OF VIAL RUBBER FALLING INTO THE VIAL WHEN THE PROTECTOR IS INSERTED INTO THE VIAL.

Additional Manufacturer Narrative · 1

A DEVICE EVALUATION AND/OR DEVICE HISTORY REVIEW IS ANTICIPATED, BUT IS NOT COMPLETE. UPON COMPLETION, A SUPPLEMENTAL REPORT WILL BE FILED.

Description of Event or Problem · 1

IT HAS BEEN REPORTED THAT THE BD¿ PROTECTOR P50 HAS BEEN FOUND CONTAINING FOREIGN MATTER DURING USE. THE FOLLOWING HAS BEEN PROVIDED BY THE INITIAL REPORTER: A PIECE OF VIAL RUBBER FALLING INTO THE VIAL WHEN THE PROTECTOR IS INSERTED INTO THE VIAL.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
52585 BD PROTECTOR P50 INTRAVASCULAR ADMINISTRATION SET ONB BECTON DICKINSON, S.A. 515105 1905122 30382905151058

Patients

Seq Age Sex Outcome Treatment
1 Other